{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:41:21Z","timestamp":1790127681841,"version":"4.0.1"},"reference-count":258,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Human T-lymphotropic viruses (HTLVs) are deltaretroviruses infecting millions of individuals worldwide, with HTLV-1 and HTLV-2 being the most widespread and clinically relevant types. HTLV-1 is associated with severe diseases such as adult T-cell leukemia\/lymphoma (ATL) and HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), while HTLV-2 shows a lower pathogenic potential, with occasional links to neurological disorders. HTLV-3 and HTLV-4, identified in Central Africa, remain poorly characterized but are genetically close to their simian counterparts, indicating recent zoonotic transmission events. HTLVs replicate through a complex cycle involving cell-to-cell transmission and clonal expansion of infected lymphocytes. Viral persistence is mediated by regulatory and accessory proteins, notably Tax and HBZ in HTLV-1, which alter host cell signaling, immune responses, and genomic stability. Integration of proviral DNA into transcriptionally active regions of the host genome may contribute to oncogenesis and long-term viral latency. Differences in viral protein function and intracellular localization contribute to the distinct pathogenesis observed between HTLV-1 and HTLV-2. Geographically, HTLV-1 shows endemic clusters in southwestern Japan, sub-Saharan Africa, the Caribbean, South America, and parts of the Middle East and Oceania. HTLV-2 is concentrated among Indigenous populations in the Americas and people who inject drugs in Europe and North America. Transmission occurs primarily via breastfeeding, sexual contact, contaminated blood products, and, in some regions, zoonotic spillover. Diagnostic approaches include serological screening (ELISA, Western blot, LIA) and molecular assays (PCR, qPCR), with novel biosensor and AI-based methods under development. Despite advances in understanding viral biology, therapeutic options remain limited, and preventive strategies focus on transmission control. The long latency period, lack of effective treatments, and global neglect complicate public health responses, underscoring the need for increased awareness, research investment, and targeted interventions.<\/jats:p>","DOI":"10.3390\/v17050664","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:35:13Z","timestamp":1746185713000},"page":"664","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-3877","authenticated-orcid":false,"given":"Francesco","family":"Branda","sequence":"first","affiliation":[{"name":"Unit of Medical Statistics and Molecular Epidemiology, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Romano","sequence":"additional","affiliation":[{"name":"Unit of Medical Statistics and Molecular Epidemiology, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7685-3419","authenticated-orcid":false,"given":"Grazia","family":"Pavia","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Bilotta","sequence":"additional","affiliation":[{"name":"Unit of Medical Statistics and Molecular Epidemiology, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Locci","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"},{"name":"Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Azzena","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3657-8740","authenticated-orcid":false,"given":"Ilaria","family":"Deplano","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Pascale","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"},{"name":"Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy"},{"name":"Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perra","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"},{"name":"Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5849-7326","authenticated-orcid":false,"given":"Marta","family":"Giovanetti","sequence":"additional","affiliation":[{"name":"Department of Science and Technologies for Sustainable Development and One Health, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"},{"name":"Instituto Rene Rachou, Funda\u00e7\u00e3o Oswaldo Cruz-FIOCRUZ, Belo Horizonte 30190-009, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ciccozzi","sequence":"additional","affiliation":[{"name":"Facolt\u00e0 Dipartimentale di Scienze e Tecnologie per lo Sviluppo Sostenibile e One Health, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-5400","authenticated-orcid":false,"given":"Andrea","family":"De Vito","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Quirino","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0880-8955","authenticated-orcid":false,"given":"Nadia","family":"Marascio","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Matera","sequence":"additional","affiliation":[{"name":"Unit of Clinical Microbiology, Department of Health Sciences, \u201cMagna Gr\u00e6cia\u201d University of Catanzaro\u2014\u201cRenato Dulbecco\u201d Teaching Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-2273","authenticated-orcid":false,"given":"Giordano","family":"Madeddu","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-4851","authenticated-orcid":false,"given":"Marco","family":"Casu","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-4663","authenticated-orcid":false,"given":"Daria","family":"Sanna","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-3180","authenticated-orcid":false,"given":"Giancarlo","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, University of Rome Sapienza, 00161 Rome, Italy"},{"name":"Azienda Ospedaliero Universitaria Umberto I, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-9239","authenticated-orcid":false,"given":"Massimo","family":"Ciccozzi","sequence":"additional","affiliation":[{"name":"Unit of Medical Statistics and Molecular Epidemiology, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3501-714X","authenticated-orcid":false,"given":"Fabio","family":"Scarpa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4690-2-30","article-title":"Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa","volume":"2","author":"Calattini","year":"2005","journal-title":"Retrovirology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.patbio.2008.02.015","article-title":"The human HTLV-3 and HTLV-4 retroviruses: New members of the HTLV family","volume":"57","author":"Mahieux","year":"2009","journal-title":"Pathol. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00078-21","DOI":"10.1128\/cmr.00078-21","article-title":"Clinical and public health implications of human T-lymphotropic virus type 1 infection","volume":"35","author":"Legrand","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Einsiedel, L., Pham, H., Talukder, M.R., Taylor, K., Wilson, K., Kaldor, J., Gessain, A., and Woodman, R. (2021). Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community survey. PLoS Neglect. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009915"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gessain, A., Ramassamy, J.L., Afonso, P.V., and Cassar, O. (2023). Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world\u2019s largest endemic area. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1043600"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107018","DOI":"10.1016\/j.ijid.2024.107018","article-title":"Prevalence of HTLV-1\/2 infection in pregnant women in Central and South America and the Caribbean: A systematic review and meta-analysis","volume":"143","author":"Soriano","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Itabashi, K., Miyazawa, T., and Uchimaru, K. (2023). How can we prevent mother-to-child transmission of HTLV-1?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086961"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nunes, D., Boa-Sorte, N., Grassi, M.F.R., Taylor, G.P., Teixeira, M.G., Barreto, M.L., Dourado, I., and Galv\u00e3o-Castro, B. (2017). HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171303"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/infdis\/jiac312","article-title":"Epidemiological evidence of nosocomial and zoonotic transmission of human T-cell leukemia virus-1 in a large survey in a rural population of Central Africa","volume":"227","author":"Ramassamy","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: Persistence and pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.6981847","article-title":"A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia","volume":"218","author":"Kalyanaraman","year":"1982","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1038\/sj.onc.1208971","article-title":"Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2","volume":"24","author":"Feuer","year":"2005","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(92)90797-7","article-title":"Chronic neurodegenerative disease associated with HTLV-II infection","volume":"339","author":"Hjelle","year":"1992","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Marinho, T.A., Okita, M.T., Guimar\u00e3es, R.A., Zara, A.L.d.S.A., Caetano, K.A.A., Teles, S.A., de Matos, M.A.D., Carneiro, M.A.d.S., and Martins, R.M.B. (2024). The Global Prevalence of HTLV-1 and HTLV-2 Infections among Immigrants and Refugees\u2014A Systematic Review and Meta-Analysis. Viruses, 16.","DOI":"10.3390\/v16101526"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Barbeau, B., Peloponese, J.M., and Mesnard, J.M. (2013). Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00226"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12977-019-0483-0","article-title":"Comparative virology of HTLV-1 and HTLV-2","volume":"16","author":"Martinez","year":"2019","journal-title":"Retrovirology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1073\/pnas.0501734102","article-title":"Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters","volume":"102","author":"Wolfe","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9876","DOI":"10.1128\/JVI.00799-06","article-title":"Human T-cell lymphotropic virus type 3: Complete nucleotide sequence and characterization of the human tax3 protein","volume":"80","author":"Calattini","year":"2006","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1089\/aid.2008.0128","article-title":"Absence of evidence of HTLV-3 and HTLV-4 in patients with large granular lymphocyte (LGL) leukemia","volume":"24","author":"Duong","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/aid.2009.0124","article-title":"LGL leukemia and HTLV","volume":"26","author":"Thomas","year":"2010","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chevalier, S.A., Durand, S., Dasgupta, A., Radonovich, M., Cimarelli, A., Brady, J.N., Mahieux, R., and Pise-Masison, C.A. (2012). The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: Insights into HTLV-3 potential leukemogenic properties. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041003"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1016\/S2666-5247(23)00359-2","article-title":"Human T-lymphotropic virus type 1 and antiretroviral therapy: Practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease","volume":"5","author":"Jaberolansar","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_26","first-page":"174","article-title":"Human T-lymphotropic virus type I and breastfeeding; systematic review and meta-analysis of the literature","volume":"17","author":"Boostani","year":"2018","journal-title":"Iran. J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/429410","article-title":"A prospective study of sexual transmission of human T lymphotropic virus (HTLV)\u2013I and HTLV-II","volume":"191","author":"Roucoux","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/trf.12105","article-title":"Human T-lymphotropic virus lookback in NHS B lood and T ransplant (E ngland) reveals the efficacy of leukoreduction","volume":"53","author":"Hewitt","year":"2013","journal-title":"Transfusion"},{"key":"ref_29","unstructured":"World Health Organization (2021). Public Health Impact and Implications for Future Actions: WHO Global Consultation on the Human T-Lymphotropic Virus Type 1, Tokyo, Japan, 13\u201315 November 2019."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(20)30328-5","article-title":"Human T-cell lymphotropic virus type-1: A lifelong persistent infection, yet never truly silent","volume":"21","author":"Hirons","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(21)00063-3","article-title":"Horizontal transmission of HTLV-1 causing uveitis","volume":"21","author":"Kamoi","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/299367a0","article-title":"Unique cell lines harbouring both Epstein\u2013Barr virus and adult T-cell leukaemia virus, established from leukaemia patients","volume":"299","author":"Yamamoto","year":"1982","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1073\/pnas.81.23.7588","article-title":"Infection of human endothelial cells by human T-lymphotropic virus type I","volume":"81","author":"Ho","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/310505a0","article-title":"Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia","volume":"310","author":"Longo","year":"1984","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1084\/jem.176.1.293","article-title":"In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II)","volume":"176","author":"Ijichi","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1128\/JVI.72.9.7609-7614.1998","article-title":"Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2","volume":"72","author":"Rosenberg","year":"1998","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","article-title":"The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV","volume":"115","author":"Manel","year":"2003","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.1128\/JVI.77.18.9922-9930.2003","article-title":"Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans","volume":"77","author":"Pinon","year":"2003","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1128\/JVI.00389-06","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells","volume":"80","author":"Jones","year":"2006","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/2261211a0","article-title":"RNA-dependent DNA polymerase in virions of Rous sarcoma virus","volume":"226","author":"Temin","year":"1970","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/2261209a0","article-title":"Viral RNA-dependent DNA polymerase: RNA-dependent DNA polymerase in virions of RNA tumour viruses","volume":"226","author":"Baltimore","year":"1970","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1073\/pnas.89.12.5532","article-title":"Nonrandom integration of retroviral DNA in vitro: Effect of CpG methylation","volume":"89","author":"Kitamura","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2004-11-4350","article-title":"Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states","volume":"106","author":"Doi","year":"2005","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1073\/pnas.0501646102","article-title":"Symmetrical base preferences surrounding HIV-1, avian sarcoma\/leukosis virus, and murine leukemia virus integration sites","volume":"102","author":"Holman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1128\/JVI.02752-06","article-title":"Human T-cell leukemia virus type 1 integration target sites in the human genome: Comparison with those of other retroviruses","volume":"81","author":"Derse","year":"2007","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1743-422X-11-172","article-title":"HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM\/TSP","volume":"11","author":"Niederer","year":"2014","journal-title":"Virol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/sj.onc.1208973","article-title":"Transcriptional and post-transcriptional gene regulation of HTLV-1","volume":"24","author":"Kashanchi","year":"2005","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/376606a0","article-title":"Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax","volume":"376","author":"Baranger","year":"1995","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/j.1460-2075.1988.tb02840.x","article-title":"Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins","volume":"7","author":"Hidaka","year":"1988","journal-title":"EMBO J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1128\/JVI.76.7.3089-3094.2002","article-title":"Destiny of unspliced retroviral RNA: Ribosome and\/or virion?","volume":"76","author":"Butsch","year":"2002","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bpj.2011.02.008","article-title":"Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopy","volume":"100","author":"Fogarty","year":"2011","journal-title":"Biophys. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.virol.2015.03.021","article-title":"Retroviral proteases and their roles in virion maturation","volume":"479","author":"Konvalinka","year":"2015","journal-title":"Virology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1128\/JVI.03113-15","article-title":"Functional comparison of HBZ and the related APH-2 protein provides insight into human T-cell leukemia virus type 1 pathogenesis","volume":"90","author":"Panfil","year":"2016","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Panfil, A.R., Al-Saleem, J., Howard, C.M., Shkriabai, N., Kvaratskhelia, M., and Green, P.L. (2018). Stability of the HTLV-1 antisense-derived protein, HBZ, is regulated by the E3 ubiquitin-protein ligase, UBR5. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00080"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/v3071074","article-title":"HTLV-3\/STLV-3 and HTLV-4 viruses: Discovery, epidemiology, serology and molecular aspects","volume":"3","author":"Mahieux","year":"2011","journal-title":"Viruses"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2012.09.035","article-title":"HTLV-3\/4 and simian foamy retroviruses in humans: Discovery, epidemiology, cross-species transmission and molecular virology","volume":"435","author":"Gessain","year":"2013","journal-title":"Virology"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Romanelli, M.G., Diani, E., Bergamo, E., Casoli, C., Ciminale, V., Bex, F., and Bertazzoni, U. (2013). Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00271"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e28424","DOI":"10.1002\/jmv.28424","article-title":"HTLV-1 persistent infection and ATLL oncogenesis","volume":"95","author":"Zuo","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coviro.2021.04.003","article-title":"Innate immunity and HBV persistence","volume":"49","author":"Chiale","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e29708","DOI":"10.1002\/jmv.29708","article-title":"Persistence of SARS-CoV-2 infection and viral intra-and inter-host evolution in COVID-19 hospitalized patients","volume":"96","author":"Pavia","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Marascio, N., Mazzitelli, M., Pavia, G., Giancotti, A., Barreca, G.S., Costa, C., Pisani, V., Greco, G., Serapide, F., and Trecarichi, E.M. (2019). Clinical, virological characteristics, and outcomes of treatment with sofosbuvir\/ledipasvir in two pediatric patients infected by HCV genotype 4. Cells, 8.","DOI":"10.3390\/cells8050416"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jmv.25073","article-title":"Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling","volume":"90","author":"Marascio","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Marascio, N., Pavia, G., Strazzulla, A., Dierckx, T., Cuypers, L., Vrancken, B., Barreca, G.S., Mirante, T., Malanga, D., and Oliveira, D.M. (2016). Detection of natural resistance-associated substitutions by ion semiconductor technology in HCV1b positive, direct-acting antiviral agents-na\u00efve patients. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091416"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1002\/slct.201800649","article-title":"Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Na\u00efve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity","volume":"3","author":"Romeo","year":"2018","journal-title":"ChemistrySelect"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.coviro.2012.06.007","article-title":"Mechanisms of human T-lymphotropic virus type 1 transmission and disease","volume":"2","author":"Lairmore","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Forlani, G., Shallak, M., Accolla, R.S., and Romanelli, M.G. (2021). HTLV-1 infection and pathogenesis: New insights from cellular and animal models. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158001"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gross, C., and Thoma-Kress, A.K. (2016). Molecular mechanisms of HTLV-1 cell-to-cell transmission. Viruses, 8.","DOI":"10.3390\/v8030074"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/jcm.30.4.905-910.1992","article-title":"Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma\/leukemia virus type I","volume":"30","author":"Fan","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Majorovits, E., Nejmeddine, M., Tanaka, Y., Taylor, G.P., Fuller, S.D., and Bangham, C.R. (2008). Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002251"},{"key":"ref_70","first-page":"1016","article-title":"HTLV-1\u2013Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse","volume":"114","author":"Nejmeddine","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1074\/jbc.M109.051334","article-title":"C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism","volume":"285","author":"Qualley","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"29653","DOI":"10.1074\/jbc.M502639200","article-title":"Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse","volume":"280","author":"Nejmeddine","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.2910520316","article-title":"Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines","volume":"52","author":"Fukudome","year":"1992","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Chevalier, S.A., Turpin, J., Cachat, A., Afonso, P.V., Gessain, A., Brady, J.N., Pise-Masison, C.A., and Mahieux, R. (2014). Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003917"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses","volume":"16","author":"Sachse","year":"2010","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/jvi.66.4.2288-2295.1992","article-title":"Low degree of human T-cell leukemia\/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations","volume":"66","author":"Gessain","year":"1992","journal-title":"J. Virol."},{"key":"ref_77","first-page":"603","article-title":"The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains","volume":"21","author":"Pybus","year":"2004","journal-title":"Mol. Biol. Evol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0304-3835(98)00188-8","article-title":"Random integration of HTLV-I provirus; increasing chromosomal instability","volume":"132","author":"Ohshima","year":"1998","journal-title":"Cancer Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/jvi.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J. Virol."},{"key":"ref_80","first-page":"4862","article-title":"Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo","volume":"57","author":"Etoh","year":"1997","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Shirinian, M., Kfoury, Y., Dassouki, Z., El-Hajj, H., and Bazarbachi, A. (2013). Tax-1 and Tax-2 similarities and differences: Focus on post-translational modifications and NF-\u03baB activation. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00231"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/nar\/25.2.379","article-title":"HTLV-I Tax self-association in optimal trans-activation function","volume":"25","author":"Jin","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-5-76","article-title":"The HTLV-1 tax interactome","volume":"5","author":"Boxus","year":"2008","journal-title":"Retrovirology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"26270","DOI":"10.1074\/jbc.M115.684746","article-title":"Akt pathway activation by human T-cell leukemia virus type 1 Tax oncoprotein","volume":"290","author":"Cherian","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"43307","DOI":"10.1074\/jbc.M400497200","article-title":"A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution","volume":"279","author":"Meertens","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Journo, C., Filipe, J., About, F., Chevalier, S.A., Afonso, P.V., Brady, J.N., Flynn, D., Tangy, F., Israel, A., and Vidalain, P.O. (2009). NRP\/optineurin cooperates with TAX1BP1 to potentiate the activation of NF-\u03baB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000521"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/JVI.01792-12","article-title":"Human T cell leukemia virus type 2 tax-mediated NF-\u03baB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO","volume":"87","author":"Journo","year":"2013","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Shibata, Y., Tokunaga, F., Goto, E., Komatsu, G., Gohda, J., Saeki, Y., Tanaka, K., Takahashi, H., Sawasaki, T., and Inoue, S. (2017). HTLV-1 tax induces formation of the active macromolecular IKK complex by generating Lys63-and Met1-linked hybrid polyubiquitin chains. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006162"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11262-015-1277-7","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52\/p100 and RelB","volume":"52","author":"Motai","year":"2016","journal-title":"Virus Genes"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1742-4690-9-102","article-title":"Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-\u03baB activity: A comparative study with the HTLV-1 Tax-1 protein","volume":"9","author":"Turci","year":"2012","journal-title":"Retrovirology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.onc.1203450","article-title":"HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration","volume":"19","author":"Ariumi","year":"2000","journal-title":"Oncogene"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Nicot, C. (2015). HTLV-I Tax-mediated inactivation of cell cycle checkpoints and DNA repair pathways contribute to cellular transformation: \u201cA random mutagenesis model\u201d. J. Cancer Sci., 2.","DOI":"10.13188\/2377-9292.1000009"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray","year":"2002","journal-title":"J. Virol."},{"key":"ref_94","first-page":"2427","article-title":"Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription","volume":"114","author":"Halin","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1128\/JVI.00717-12","article-title":"Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo","volume":"86","author":"Yin","year":"2012","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1128\/JVI.75.23.11515-11525.2001","article-title":"Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells","volume":"75","author":"Hakata","year":"2001","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/jvi.71.4.2810-2818.1997","article-title":"Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs","volume":"71","author":"Ciminale","year":"1997","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1128\/JVI.78.20.11077-11083.2004","article-title":"Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator","volume":"78","author":"Younis","year":"2004","journal-title":"J. Virol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/JVI.80.7.3469-3476.2006","article-title":"Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II is required for viral infectivity in vivo","volume":"80","author":"Hiraragi","year":"2006","journal-title":"J. Virol."},{"key":"ref_100","first-page":"3809","article-title":"Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits","volume":"116","author":"Valeri","year":"2010","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/viro.1996.0487","article-title":"Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load","volume":"223","author":"Cimarelli","year":"1996","journal-title":"Virology"},{"key":"ref_102","first-page":"485","article-title":"HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases","volume":"32","author":"Anguita","year":"2019","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gessain, A., and Cassar, O. (2012). Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol., 3.","DOI":"10.3389\/fmicb.2012.00388"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Brito, W.R.d.S., Cardoso-Costa, G.d.L., Roland Junior, L.M., Pereira, K.A.S., Lopes, F.T., Santos, B.C.d., de Lima, A.C.R., Abreu, I.N., Lima, C.N.C., and Lima, S.S. (2022). Prevalence and risk factors for HTLV-1\/2 infection in quilombo remnant communities living in the Brazilian Amazon. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.871865"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/infdis\/jit558","article-title":"HTLV-1 and HTLV-2 prevalence in the United States","volume":"209","author":"Cook","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ishak, R., de Oliveira Guimar\u00e3es Ishak, M., Abreu, I.N., Machado, L.F.A., Lima, S.S., Queiroz, M.A.F., Cayres-Vallinoto, I.M., Guerreiro, J.F., and Vallinoto, A.C.R. (2023). Long-term prevalence follow-up (1967\u20132022) of HTLV-2 among vulnerable indigenous populations in the Amazon region of Brazil. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1217134"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/00365540600617009","article-title":"HTLV-2 infection in injection drug users in King County, Washington","volume":"38","author":"Zunt","year":"2006","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors","volume":"48","author":"Murphy","year":"1997","journal-title":"Neurology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"veaa053","DOI":"10.1093\/ve\/veaa053","article-title":"HTLV in South America: Origins of a silent ancient human infection","volume":"6","author":"Ishak","year":"2020","journal-title":"Virus Evol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Djuicy, D.D., Mouinga-Ond\u00e9m\u00e9, A., Cassar, O., Ramassamy, J.L., Idam Mamimandjiami, A., Bikangui, R., Fontanet, A., and Gessain, A. (2018). Risk factors for HTLV-1 infection in Central Africa: A rural population-based survey in Gabon. PLoS Neglect. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006832"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Proietti","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_112","first-page":"1162","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: Association with antibodies to envelope glycoprotein (gp46) epitopes","volume":"6","author":"Wiktor","year":"1993","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.2910490508","article-title":"Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I","volume":"49","author":"Takahashi","year":"1991","journal-title":"Int. J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00042560-199606010-00013","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I\/II) in Gabon: A prospective follow-up of 4 years","volume":"12","author":"Nyambi","year":"1996","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/423941","article-title":"Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I","volume":"190","author":"Li","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_116","first-page":"572","article-title":"Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells","volume":"120","author":"Mallet","year":"2012","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tracli.2015.12.001","article-title":"Infection with human T-lymphotropic virus types-1 and-2 (HTLV-1 and-2): Implications for blood transfusion safety","volume":"23","author":"Murphy","year":"2016","journal-title":"Transfus. Clin. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM199202063260604","article-title":"Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases","volume":"326","author":"Khabbaz","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cid\/civ145","article-title":"A severe bite from a nonhuman primate is a major risk factor for HTLV-1 infection in hunters from Central Africa","volume":"60","author":"Filippone","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/infdis\/jiu464","article-title":"Origin of HTLV-1 in hunters of nonhuman primates in Central Africa","volume":"211","author":"Kazanji","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.7","article-title":"A gorilla reservoir for human T-lymphotropic virus type 4","volume":"3","author":"LeBreton","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Melamed, A., Laydon, D.J., Gillet, N.A., Tanaka, Y., Taylor, G.P., and Bangham, C.R. (2013). Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003271"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cell.2015.04.004","article-title":"Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions","volume":"161","author":"Kraft","year":"2015","journal-title":"Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.1423199113","article-title":"The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome","volume":"113","author":"Satou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrg.2016.139","article-title":"Regulatory activities of transposable elements: From conflicts to benefits","volume":"18","author":"Chuong","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_127","unstructured":"Gallo, R., and Willems, L. (2021). Proviral latency and the reprogramming of host gene expression in HTLV-1 infection. Front. Microbiol., 12."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/bloodadvances.2017005900","article-title":"Clonality of HTLV-1\u2013infected T cells as a risk indicator for development of adult T-cell leukemia","volume":"1","author":"Firouzi","year":"2017","journal-title":"Blood Adv."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Ratner, L. (2022). Epigenetic Regulation of Human T-Cell Leukemia Virus Gene Expression. Microorganisms, 10.","DOI":"10.3390\/microorganisms10010084"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis","volume":"6","author":"Matsuoka","year":"2009","journal-title":"Retrovirology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/onc.2010.537","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: Viral infectivity, Tax, HBZ and therapy","volume":"30","author":"Matsuoka","year":"2011","journal-title":"Oncogene"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Panfil, A.R., Green, P.L., and Yoder, K.E. (2020). CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.580371"},{"key":"ref_134","unstructured":"Leonardi, F.e.a. (2020). Deep learning applied to classification of HTLV subtypes. Front. Genet., 11."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"100674","DOI":"10.1016\/j.patter.2022.100674","article-title":"Deep learning for detecting and elucidating human T-cell leukemia virus type 1 integration in the human genome","volume":"4","author":"Xu","year":"2023","journal-title":"Patterns (NY)"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e36245","DOI":"10.7554\/eLife.36245","article-title":"The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis","volume":"7","author":"Melamed","year":"2018","journal-title":"Elife"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/s41375-020-0981-z","article-title":"Determinants and role of chromatin organization in acute leukemia","volume":"34","author":"Fang","year":"2020","journal-title":"Leukemia"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Yaguchi, H., Melamed, A., Ramanayake, S., Kiik, H., Witkover, A., and Bangham, C.R.M. (2024). The impact of HTLV-1 expression on the 3D structure and expression of host chromatin. PLoS Pathog., 20, (3).","DOI":"10.1371\/journal.ppat.1011716"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.leukres.2025.107680","article-title":"Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: Immune evasion and clonal expansion","volume":"152","author":"Shichijo","year":"2025","journal-title":"Leuk. Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Chen, M., Huang, X., Wang, C., Wang, S., Jia, L., and Li, L. (2024). Endogenous retroviral solo-LTRs in human genome. Front. Genet., 15.","DOI":"10.3389\/fgene.2024.1358078"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Smith, S., Seth, J., Midkiff, A., Stahl, R., Syu, Y.-C., Shkriabai, N., Kvaratskhelia, M., Musier-Forsyth, K., Jain, P., and Green, P.L. (2023). The Pleiotropic Effects of YBX1 on HTLV-1 Transcription. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713119"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Baydoun, H.H., Bai, X.T., Shelton, S., and Nicot, C. (2012). HTLV-I Tax Increases Genetic Instability by Inducing DNA Double Strand Breaks during DNA Replication and Switching Repair to NHEJ. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042226"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"110826","DOI":"10.1016\/j.isci.2024.110826","article-title":"Diffusion of activated ATM explains \u03b3H2AX and MDC1 spread beyond the DNA damage site","volume":"27","author":"Danovski","year":"2024","journal-title":"iScience"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.2019002665","article-title":"Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis","volume":"135","author":"Rowan","year":"2020","journal-title":"Blood"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/CCO.0000000000000883","article-title":"HTLV-1-related adult T-cell leukemia\/lymphoma: Insights in early detection and management","volume":"34","author":"Wolf","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"ref_147","first-page":"224","article-title":"Prevalence of human T-lymphotropic virus type 1 (HTLV-1) infection in patients with hematologic disorders and non-hematologic malignancies in a tertiary referral hospital","volume":"20","author":"Jalaeikhoo","year":"2017","journal-title":"Arch. Iran. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"57","DOI":"10.18869\/acadpub.ibj.21.1.57","article-title":"Seroepidemiology of HTLV-1 and HTLV-2 infection in Neyshabur city, North-Eastern Iran, during 2010\u20132014","volume":"21","author":"Salehi","year":"2017","journal-title":"Iran. Biomed. J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/JCM.37.5.1324-1328.1999","article-title":"Evaluation of the INNO-LIA HTLV I\/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations","volume":"37","author":"Sabino","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e0853-2020","DOI":"10.1590\/0037-8682-0853-2020","article-title":"Specificity of HTLV screening tests and its impact on health care program costs: The perspective of antenatal screening in Brazil","volume":"54","author":"Rosadas","year":"2021","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_151","first-page":"10","article-title":"Performance of commercially available serological screening tests for human T-cell lymphotropic virus infection in Brazil","volume":"56","author":"Santos","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood.V81.6.1641.1641","article-title":"Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors","volume":"81","author":"Hjelle","year":"1993","journal-title":"Blood"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/v3081320","article-title":"The prevalence and significance of HTLV-I\/II seroindeterminate Western blot patterns","volume":"3","author":"Abrams","year":"2011","journal-title":"Viruses"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jmv.25014","article-title":"Confirmatory molecular method for HTLV-1\/2 infection in high-risk pregnant women","volume":"90","author":"Medeiros","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_155","first-page":"165","article-title":"Diagn\u00f3stico serol\u00f3gico de HTLV-1\/2: Combinaci\u00f3n de t\u00e9cnicas de tamizaje para definir el estatus serol\u00f3gico en donantes de sangre","volume":"45","author":"Moreno","year":"2013","journal-title":"Rev. Argent. Microbiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1002\/jcp.28087","article-title":"Current approaches for detection of human T-lymphotropic virus Type 1: A systematic review","volume":"234","author":"Fani","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Cassar, O., and Gessain, A. (2017). Serological and molecular methods to study epidemiological aspects of human T-cell lymphotropic virus type 1 infection. Human T-Lymphotropic Viruses: Methods and Protocols, Humana Press.","DOI":"10.1007\/978-1-4939-6872-5_1"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1099-1069(199606)14:2<91::AID-HON574>3.0.CO;2-G","article-title":"Detection of human T lymphotrophic virus type I (HTLV-I) DNA and mRNA in individual cells by polymerase chain reaction (PCR) in situ hybridization (ISH) and reverse transcription (RT)-PCR ISH","volume":"14","author":"Ohshima","year":"1996","journal-title":"Hematol. Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1007\/s00705-021-05204-w","article-title":"An overview of sequencing technology platforms applied to HTLV-1 studies: A systematic review","volume":"166","author":"Cucco","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100194","DOI":"10.1016\/j.jcvp.2024.100194","article-title":"Next generation sequencing-based transcriptome data mining for virus identification and characterization: Review on recent progress and prospect","volume":"4","author":"Rahimian","year":"2024","journal-title":"J. Clin. Virol. Plus"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11033-021-06959-w","article-title":"Comparison between various biosensor methods for human T-lymphotropic virus-1 (HTLV-1) detection","volume":"49","author":"Kamali","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Vigneshvar, S., Sudhakumari, C., Senthilkumaran, B., and Prakash, H. (2016). Recent advances in biosensor technology for potential applications\u2014An overview. Front. Bioeng. Biotechnol., 4.","DOI":"10.3389\/fbioe.2016.00011"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Karunakaran, C., Rajkumar, R., and Bhargava, K. (2015). Introduction to biosensors. Biosensors and Bioelectronics, Elsevier.","DOI":"10.1016\/B978-0-12-803100-1.00001-3"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jab.2013.02.001","article-title":"Advances in biosensors: Principle, architecture and applications","volume":"12","author":"Perumal","year":"2014","journal-title":"J. Appl. Biomed."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bios.2017.07.047","article-title":"Recent advances in biosensor technology in assessment of early diabetes biomarkers","volume":"99","author":"Vakhshiteh","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Silveira, C.M., Monteiro, T., and Almeida, M.G. (2016). Biosensing with paper-based miniaturized printed electrodes\u2013a modern trend. Biosensors, 6.","DOI":"10.3390\/bios6040051"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Santos, F.A., Cat\u00e3o, C.L.S., Martins, J.P., Pessoa, U.H.S., Sousa, I.V., Melo, J.S., Souza, G.L., Ara\u00fajo, N.D., Magalh\u00e3es-Gama, F., and Abrahim, C.M.d.M. (2024). Performance of immunological assays for universal and differential diagnosis of HTLV-1\/2 infection in candidates for blood donations from the Brazilian Amazon. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0298710"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Matavele Chissumba, R., Silva-Barbosa, S.D., Augusto, \u00c2., Maueia, C., Mabunda, N., Gudo, E.S., Bhatt, N., Jani, I., and Savino, W. (2015). CD4+ CD25 High Treg cells in HIV\/HTLV co-infected patients with neuropathy: High expression of Alpha4 integrin and lower expression of Foxp3 transcription factor. BMC Immunol., 16.","DOI":"10.1186\/s12865-015-0116-x"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Freitas, N.L., Gomes, Y.C.P., Souza, F.d.S., Torres, R.C., Echevarria-Lima, J., Leite, A.C.C.B., Lima, M.A.S.D., Ara\u00fajo, A.Q.C., Silva, M.T.T., and Esp\u00edndola, O.d.M. (2022). Lessons from the cerebrospinal fluid analysis of HTLV-1-infected individuals: Biomarkers of inflammation for HAM\/TSP development. Viruses, 14.","DOI":"10.3390\/v14102146"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1109\/TCBB.2019.2944610","article-title":"Hybrid machine learning models for predicting types of Human T-cell Lymphotropic Virus","volume":"18","author":"Sharma","year":"2019","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Wang, T.T., Hirons, A., Doerflinger, M., Morris, K.V., Ledger, S., Purcell, D.F., Kelleher, A.D., and Ahlenstiel, C.L. (2024). Current state of therapeutics for HTLV-1. Viruses, 16.","DOI":"10.3390\/v16101616"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"107598","DOI":"10.1016\/j.leukres.2024.107598","article-title":"Therapeutic advances for the management of adult T cell leukemia: Where do we stand?","volume":"147","author":"Hermine","year":"2024","journal-title":"Leuk. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1089\/aid.2022.0028","article-title":"Human T lymphotropic virus 1-associated myelopathy: Overview of human T cell lymphotropic virus-1\/2 tests and potential biomarkers","volume":"38","author":"Poton","year":"2022","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_174","first-page":"1211","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: A nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma","volume":"29","author":"Hodson","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-3-63","article-title":"Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: A randomised trial","volume":"3","author":"Taylor","year":"2006","journal-title":"Retrovirology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1128\/JVI.73.12.10289-10295.1999","article-title":"Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy","volume":"73","author":"Taylor","year":"1999","journal-title":"J. Virol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Macchi, B., Balestrieri, E., Ascolani, A., Hilburn, S., Martin, F., Mastino, A., and Taylor, G.P. (2011). Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors. Viruses, 3.","DOI":"10.3390\/v3050469"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jac\/dkr404","article-title":"Antiviral effect of raltegravir on HTLV-1 carriers","volume":"67","author":"Trevino","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcv.2013.12.010","article-title":"Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir","volume":"59","author":"Cabrera","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/acn3.51437","article-title":"Clinical trial of raltegravir, an integrase inhibitor, in HAM\/TSP","volume":"8","author":"Billioux","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Fernandez, T., Marconi, C., Monta\u00f1o-Castell\u00f3n, I., Deminco, F., and Brites, C. (2024). A Systematical Review on ART Use in HTLV Infection: Clinical, Virological, and Immunological Outcomes. Pathogens, 13.","DOI":"10.20944\/preprints202407.0897.v1"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"107395","DOI":"10.1016\/j.actatropica.2024.107395","article-title":"Low-cost and simple PCR process for access to molecular diagnosis of HTLV-1\/2 in low-resource countries","volume":"260","author":"Ducasa","year":"2024","journal-title":"Acta Trop."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/HAB-200435","article-title":"Sero-epidemiology of human T-cell lymphotropic viruses-1 and -2 infection among pregnant women attending Abuja Teaching Hospital, Nigeria","volume":"29","author":"Dangana","year":"2021","journal-title":"Hum. Antibodies"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0887-7963(91)70197-1","article-title":"Human T-cell lymphotropic virus type I and II in transfusion medicine","volume":"5","author":"Sandler","year":"1991","journal-title":"Transfus. Med. Rev."},{"key":"ref_186","first-page":"2049936119851464","article-title":"Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana","volume":"6","author":"Bautista","year":"2019","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_187","first-page":"e49169","article-title":"A Textbook Case of Human T-lymphotropic Virus-1 (HTLV-1)-Induced Adult T-cell Leukemia Treated With Cyclophosphamide, Hydroxydaunorubicin, Oncovin, and Prednisone\/Prednisolone (CHOP)","volume":"15","author":"Altaf","year":"2023","journal-title":"Cureus"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000534040","article-title":"Poor Outcome of Adult T-Cell Leukemia\/Lymphoma with Current Available Therapy: An Experience of Two Centers","volume":"46","author":"Saeed","year":"2023","journal-title":"Oncol. Res. Treat."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","article-title":"Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy","volume":"24","author":"Taylor","year":"2005","journal-title":"Oncogene"},{"key":"ref_190","first-page":"1407","article-title":"Clinical Study of Chemotherapy Combined with Antivirals for Adult T-cell Leukemia\/Lymphoma","volume":"30","author":"Lin","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12185-023-03572-4","article-title":"Current and emerging therapeutic strategies in adult T-cell leukemia\u2013lymphoma","volume":"117","author":"Katsuya","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: A randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_194","first-page":"758","article-title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment","volume":"132","author":"Sakamoto","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/bjh.15123","article-title":"Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: Impact on allogeneic haematopoietic stem cell transplantation","volume":"184","author":"Ishida","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3324\/haematol.2021.280352","article-title":"Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia\/lymphoma","volume":"107","author":"Tanaka","year":"2022","journal-title":"Haematologica"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.18281","article-title":"Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma","volume":"198","author":"Shichijo","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/hon.2712","article-title":"Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience","volume":"38","author":"Sakamoto","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41409-018-0291-5","article-title":"Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation","volume":"54","author":"Inoue","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hon.3115","article-title":"Lenalidomide treatment for recurrent adult T-cell leukemia\/lymphoma after allogeneic hematopoietic cell transplantation","volume":"41","author":"Tanaka","year":"2023","journal-title":"Hematol. Oncol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3109\/10428194.2013.780289","article-title":"Bortezomib salvage therapy in refractory acute adult T-cell leukemia\/lymphoma","volume":"54","author":"Hourigan","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1038\/bcj.2016.21","article-title":"Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma","volume":"6","author":"Ratner","year":"2016","journal-title":"Blood Cancer J."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41409-019-0446-z","article-title":"VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: A propensity score analysis","volume":"54","author":"Fuji","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bmt.2015.265","article-title":"Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma","volume":"51","author":"Fuji","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bmt.2010.92","article-title":"Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: Results of prospective trials","volume":"46","author":"Choi","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref_208","first-page":"1734","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: A nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/s41409-021-01445-0","article-title":"Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma","volume":"56","author":"Inoue","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/bloodadvances.2021004932","article-title":"Improved survival of patients with aggressive ATL by increased use of allo-HCT: A prospective observational study","volume":"5","author":"Ito","year":"2021","journal-title":"Blood Adv."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12185-013-1307-y","article-title":"Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia\/lymphoma: A retrospective analysis of the Nagasaki Transplantation Network","volume":"97","author":"Fukushima","year":"2013","journal-title":"Int. J. Hematol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.bbmt.2014.08.012","article-title":"Treatment of patients with adult T cell leukemia\/lymphoma with cord blood transplantation: A Japanese nationwide retrospective survey","volume":"20","author":"Kato","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"928.e1","DOI":"10.1016\/j.jtct.2021.07.010","article-title":"A phase I\/II multicenter trial of HLA-haploidentical PBSCT with PTCy for aggressive adult T cell leukemia\/lymphoma","volume":"27","author":"Tanaka","year":"2021","journal-title":"Transplant. Cell. Ther."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Yamauchi, J., Tanabe, K., Sato, T., Nakagawa, M., Matsuura, E., Tsuboi, Y., Tamaki, K., Sakima, H., Ishihara, S., and Ohta, Y. (2022). Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy: A randomized controlled trial (HAMLET-P). Viruses, 14.","DOI":"10.3390\/v14010136"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(94)00266-Q","article-title":"Progression of neurological disability in HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"129","author":"Leite","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Yamano, Y., and Sato, T. (2012). Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis. Front. Microbiol., 3.","DOI":"10.3389\/fmicb.2012.00389"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: A multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo","year":"1996","journal-title":"Neurology"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trials in 200 patients with HTLV-Iassociated myelopathy\/tropical spastic paraparesis","volume":"2","author":"Nakagawa","year":"1996","journal-title":"J. Neurovirol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Martin, F., Castro, H., Gabriel, C., Adonis, A., Fedina, A., Harrison, L., Brodnicki, L., Demontis, M.A., Babiker, A.G., and Weber, J.N. (2012). Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy\/tropical spastic paraparesis. PLoS Neglect. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001675"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2169\/internalmedicine.50.5013","article-title":"Successful treatment of HTLV-1-related overlap syndrome using tacrolimus","volume":"50","author":"Izumi","year":"2011","journal-title":"Intern. Med."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Sato, T., Yagishita, N., Tamaki, K., Inoue, E., Hasegawa, D., Nagasaka, M., Suzuki, H., Araya, N., Coler-Reilly, A., and Hasegawa, Y. (2018). Proposal of classification criteria for HTLV-1-associated myelopathy\/tropical spastic paraparesis disease activity. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01651"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1704827","article-title":"Mogamulizumab (Anti-CCR4) in HTLV-1\u2013associated myelopathy","volume":"378","author":"Sato","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.biopha.2017.01.005","article-title":"Comparative study of therapeutic response to baclofen vs tolperisone in spasticity","volume":"87","author":"Agarwal","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_224","first-page":"241","article-title":"Tizanidine treatment of spasticity: A meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam","volume":"15","author":"Groves","year":"1998","journal-title":"Adv. Ther."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3171\/2023.11.PEDS23473","article-title":"Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: A retrospective cohort study","volume":"33","author":"Abdelmageed","year":"2023","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Levy, J., Karam, P., Forestier, A., Loze, J.Y., and Bensmail, D. (2023). Botulinum toxin use in patients with post-stroke spasticity: A nationwide retrospective study from France. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1245228"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/nau.22952","article-title":"Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"36","author":"Troisgros","year":"2017","journal-title":"Neurourol. Urodynamics"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/ua.ua_30_24","article-title":"Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis","volume":"17","author":"Ananda","year":"2025","journal-title":"Urol. Ann."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13023-021-01990-3","article-title":"Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis: A nationwide registry study in Japan","volume":"16","author":"Iijima","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0090-4295(98)00535-4","article-title":"Alpha-adrenoceptor antagonists in neurogenic lower urinary tract dysfunction","volume":"53","author":"Sullivan","year":"1999","journal-title":"Urology"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/0004-282x20190169","article-title":"The effect of home exercise on the posture and mobility of people with HAM\/TSP: A randomized clinical trial","volume":"78","author":"Mota","year":"2020","journal-title":"Arq. Neuro-Psiquiatr."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10400435.2020.1789900","article-title":"Effects of assistive technology-based occupational therapy on community-dwelling people recovering from stroke","volume":"34","author":"Lim","year":"2022","journal-title":"Assist. Technol."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Kosse, N.M., Dutmer, A.L., Dasenbrock, L., Bauer, J.M., and Lamoth, C.J. (2013). Effectiveness and feasibility of early physical rehabilitation programs for geriatric hospitalized patients: A systematic review. BMC Geriatr., 13.","DOI":"10.1186\/1471-2318-13-107"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bjid.2018.07.003","article-title":"The impact of urinary incontinence on the quality of life and on the sexuality of patients with HAM\/TSP","volume":"22","author":"Mello","year":"2018","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bjid.2014.12.003","article-title":"HAM\/TSP and major depression: The role of age","volume":"19","author":"Borba","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.genhosppsych.2021.08.012","article-title":"Prevalence and factors associated with depression and anxiety in people living with HTLV-1: A systematic review with meta-analysis and meta-regression","volume":"73","author":"Souza","year":"2021","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1080\/09273948.2023.2175697","article-title":"Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis","volume":"31","author":"Terada","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Zong, Y., Kamoi, K., Ando, N., Kurozumi-Karube, H., and Ohno-Matsui, K. (2022). Mechanism of secondary glaucoma development in HTLV-1 uveitis. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.738742"},{"key":"ref_239","first-page":"386","article-title":"Clinical course of HTLV-1 infection associated intermediate uveitis","volume":"97","year":"2022","journal-title":"Arch. Soc. Esp. Oftalmol. (Engl. Ed.)"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Kamoi, K., Watanabe, T., Uchimaru, K., Okayama, A., Kato, S., Kawamata, T., Kurozumi-Karube, H., Horiguchi, N., Zong, Y., and Yamano, Y. (2022). Updates on HTLV-1 uveitis. Viruses, 14.","DOI":"10.3390\/v14040794"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0404.1995.tb01689.x","article-title":"Clinical characteristics of HTLV-1 associated dermato-polymyositis","volume":"92","author":"Smadja","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","article-title":"Inflammatory manifestations of HTLV-1 and their therapeutic options","volume":"10","author":"Martin","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"211","DOI":"10.24875\/AIDSRev.19000108","article-title":"HTLV-1 associated neurological complex. What is hidden below the water?","volume":"21","author":"Araujo","year":"2019","journal-title":"Aids Rev."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Dias, \u00c1.R.N., Falc\u00e3o, L.F.M., and Quaresma, J.A.S. (2022). An overview of human T-lymphotropic virus Type 1 lung injury. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.914498"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-020-00543-z","article-title":"Human T-cell leukaemia virus type 1 associated pulmonary disease: Clinical and pathological features of an under-recognised complication of HTLV-1 infection","volume":"18","author":"Einsiedel","year":"2021","journal-title":"Retrovirology"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2013.46","article-title":"A novel therapeutic molecule against HTLV-1 infection targeting provirus","volume":"27","author":"Tanaka","year":"2013","journal-title":"Leukemia"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: Mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-024-01568-z","article-title":"Advances in CAR-T-cell therapy in T-cell malignancies","volume":"17","author":"Zheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1586\/14787210.2015.1056157","article-title":"Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4","volume":"13","author":"Ambrosioni","year":"2015","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Das, C., and Kundu, C.N. (2025). Decoding the molecular complexity of viruses in human cancer: Insights into host cell infection, oncogenesis, and therapeutic prospects. Crit. Rev. Microbiol., 1\u201324.","DOI":"10.1080\/1040841X.2025.2461045"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1002\/jha2.1072","article-title":"Elimination of residual adult T-cell leukaemia clones by Tax-targeted dendritic cell vaccine","volume":"6","author":"Iino","year":"2025","journal-title":"EJHaem"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.ymthe.2024.05.020","article-title":"Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques","volume":"32","author":"Ishii","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_253","first-page":"586","article-title":"TAX and HBZ: HFc \u0263 1 proteins as targets for passive immunotherapy","volume":"25","author":"Akbarin","year":"2022","journal-title":"Iran. J. Basic Med Sci."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/2325957413500988","article-title":"HIV and HTLV-1 coinfection: The need to initiate antiretroviral therapy","volume":"12","author":"Ticona","year":"2013","journal-title":"J. Int. Assoc. Provid. AIDS Care (JIAPAC)"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Montano-Castellon, I., Marconi, C.S.C., Saffe, C., and Brites, C. (2022). Clinical and laboratory outcomes in HIV-1 and HTLV-1\/2 coinfection: A systematic review. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.820727"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Pilotti, E., Bianchi, M.V., De Maria, A., Bozzano, F., Romanelli, M.G., Bertazzoni, U., and Casoli, C. (2013). HTLV-1\/-2 and HIV-1 co-infections: Retroviral interference on host immune status. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00372"},{"key":"ref_257","first-page":"140","article-title":"Molecular and cellular interactions of HIV-1\/HTLV coinfection and impact on AIDS progression","volume":"9","author":"Casoli","year":"2007","journal-title":"Aids Rev."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Abad-Fern\u00e1ndez, M., Hern\u00e1ndez-Walias, F.J., Ruiz de Le\u00f3n, M.J., Vivancos, M.J., P\u00e9rez-El\u00edas, M.J., Moreno, A., Casado, J.L., Quereda, C., Dronda, F., and Moreno, S. (2022). HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1. Viruses, 14.","DOI":"10.3390\/v14112472"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/5\/664\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:26:01Z","timestamp":1760030761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/5\/664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":258,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["v17050664"],"URL":"https:\/\/doi.org\/10.3390\/v17050664","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}